All Type of News
Dong-A estimated 605.5 BW of sales and 50 BW of ordinary incomes in 2005.
Dong-A tentatively reported the sales and ordinary incomes of 2005 at 605 billion won and 50 billion won respectively largely due to the remarkable growth of Styrene and Nicetil.
The company announced to launch the...
Boryung to declare annual 30% growth in the new year ceremony.Boryung celebrated a new year at the 17th floor of Boryung building on Jan. 2, declaring to achieve the 2006 sales target under the slogan of "Growth maximization through a limi...
|
Hanmi IT's sales administration software to file patent registration.
Hanmi IT announced that the sales administration system called 3Call filed for the patent registration in Korea.
The 3Call system is a sales activity administration for the pharmaceutical salesmen via on or off-com...
Leadpharm to enter Kosdaq bourse via Esseltec acquisition.
Leadpharm, a pharmacy chain franchise company, is trying to enter the Kosdaq market via a detour channel.
According to the electronic public notice of Financial Supervisory Service (FSS), Leadpharm made a contract ...
KFDA revises the antibiotic standards.
The KFDA revised the standards for antibiotics covering 285 products to delete out of the total 795 products including Tetracycline guaiacol sulfonate but 510 antibiotic products to keep remained, and adjusted detaile...
KFDA to put human placenta drugs under DMF control.
A human placenta preparation, a popular drug for the treatment of climacteric symptoms, seems to be listed under the DMF (Data master file) control to reinforce its quality controls.
The KFDA announced to disclose...
Quasi-drugs issue to trigger harsh controversy.
The MOHW and KFDA recently have met with representatives from the pharmaceutical, medical and consumer group and academic experts, and indicated to run "Practical Working Council for Quasi-Drug Expansion" during Janua...
Medical devices to be conformed to international standards.
The standards and specifications for the medical device such as a blood bag, disposable syringe for injection, condom and disposable needle for injection seem to be conformed to the international standards.
The KFD...
KFDA approved clinical studies for Sewon Cellontech's Ostem.
Sewon Cellontech announced on Dec. 28 that the KFDA approved the clinical study for Ostem, a cell therapy by differentiating adult stem cells into osteoblasts to treat bone necrotic disease.
The clinical study may ...
More coverage of NHI payment for cancer patients.
The Health Insurance Review Agency (HIRA) may modify the NHI payment standards especially for the serious patients (with cancer, stroke and heart diseases) to get more NHI payment coverage while reducing the shares of...
